Literature DB >> 17584395

The self-concept of children and adolescents with neurofibromatosis type 1.

B Barton1, K North.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a genetic disorder associated with cognitive deficits, learning problems, medical complications and cosmetic disfigurement. Despite the wide-ranging impact of NF1, very few studies have examined the psychosocial adjustment of individuals with NF1, and in particular, self-concept. The aims of this study were threefold: (i) to examine the self-concept of children and adolescents with NF1; (ii) to compare the self-concept of children with NF1 (NF1 only), children with NF1 and learning difficulties [NF1 + LA (low achievement)], and children with NF1 and attention deficit hyperactivity disorder (ADHD) (NF1 + ADHD); and (iii) to examine the academic self-concept of these three groups relative to objective criteria - academic achievement and teacher ratings of academic competence.
METHODS: Measures of self-concept, academic achievement and intelligence were administered to 49 children and 26 adolescents with NF1. Parents and teachers completed behavioural rating scales.
RESULTS: The majority of children and adolescents with NF1 reported positive global self-concept, with some exceptions on specific domains. Children and adolescents with NF1 reported significantly poorer self-concept for physical abilities. Adolescents also reported significantly poorer self-concept for mathematics and general self when compared with normative mean values. Clinical severity of NF1 was not a significant predictor of self-concept for physical appearance or physical abilities. Despite a significant difference between NF1 only, NF1 + LA and NF1 + ADHD groups on measures of academic achievement and teacher ratings of academic competence, there was no significant difference between the groups for academic domains of self-concept, or any other domain of self-concept. All three groups reported inflated academic self-perceptions relative to objective criteria.
CONCLUSION: Children and adolescents with NF1 are most likely to develop negative self-concepts about their physical and sporting abilities. Inflated academic self-perceptions are discussed in light of the positive illusory bias, which may serve as an adaptive or protective function.

Entities:  

Mesh:

Year:  2007        PMID: 17584395     DOI: 10.1111/j.1365-2214.2006.00717.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  9 in total

1.  Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1.

Authors:  Rony Cohen; Tamar Steinberg; Liora Kornreich; Sharon Aharoni; Ayelet Halevy; Avinoam Shuper
Journal:  Eur J Pediatr       Date:  2014-07-16       Impact factor: 3.183

2.  Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.

Authors:  Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne
Journal:  Neuropsychol Rev       Date:  2018-08-11       Impact factor: 7.444

3.  Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study.

Authors:  Karen E Kinahan; Lisa K Sharp; Kristy Seidel; Wendy Leisenring; Aarati Didwania; Mario E Lacouture; Marilyn Stovall; Anand Haryani; Leslie L Robison; Kevin R Krull
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

4.  Cognitive deficits and positively biased self-perceptions in children with ADHD.

Authors:  Julia D McQuade; Meghan Tomb; Betsy Hoza; Daniel A Waschbusch; Elizabeth A Hurt; Aaron J Vaughn
Journal:  J Abnorm Child Psychol       Date:  2011-02

5.  Parents' experiences of caring for a young person with neurofibromatosis type 1 (NF1): a qualitative study.

Authors:  Jenny Barke; Jane Coad; Diana Harcourt
Journal:  J Community Genet       Date:  2015-07-23

6.  Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.

Authors:  David A Stevenson; John C Carey
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-08-15       Impact factor: 3.908

7.  Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood.

Authors:  Sally E Jensen; Zabin S Patel; Robert Listernick; Joel Charrow; Jin-Shei Lai
Journal:  J Clin Psychol Med Settings       Date:  2019-09

8.  Neurofibromatosis type 1 and the "elephant man's" disease: the confusion persists: an ethnographic study.

Authors:  Claire-Marie Legendre; Catherine Charpentier-Côté; Régen Drouin; Chantal Bouffard
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

9.  L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.

Authors:  Emily R Vasiljevski; Joshua Burns; Paula Bray; Gabrielle Donlevy; Anita J Mudge; Kristi J Jones; Matthew A Summers; Andrew Biggin; Craig F Munns; Marnee J McKay; Jennifer N Baldwin; David G Little; Aaron Schindeler
Journal:  Am J Med Genet A       Date:  2021-06-21       Impact factor: 2.578

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.